Search

Author/Creator Buti, Sebastiano Issue Volume 13(2021)

1. Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. (July 2021)

Authors:
Roviello, Giandomenico; Buti, Sebastiano; Cattrini, Carlo; Mennitto, Alessia; Messina, Carlo; Airoldi, Chiara; Vannini, Gianmarco; Bersanelli, Melissa
Journal:
Therapeutic advances in urology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak. (October 2021)

Authors:
Bersanelli, Melissa; Buti, Sebastiano; Rizzo, Mimma; Cortellini, Alessio; Cattrini, Carlo; Massari, Francesco; Masini, Cristina; Vitale, Maria Giuseppa; Fornarini, Giuseppe; Caffo, Orazio; Atzori, Francesco; Gatti, Alice; Macrini, Serena; Mucciarini, Claudia; Galli, Luca; Morelli, Franco; Stellat...
Journal:
Therapeutic advances in urology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). (May 2021)

Authors:
Rebuzzi, Sara Elena; Signori, Alessio; Banna, Giuseppe Luigi; Maruzzo, Marco; De Giorgi, Ugo; Pedrazzoli, Paolo; Sbrana, Andrea; Zucali, Paolo Andrea; Masini, Cristina; Naglieri, Emanuele; Procopio, Giuseppe; Merler, Sara; Tomasello, Laura; Fratino, Lucia; Baldessari, Cinzia; Ricotta, Riccardo; P...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 13(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search